Xperi Inc.
Xperi Inc. (XPER) Financial Performance & Income Statement Overview
Review Xperi Inc. (XPER) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Xperi Inc. (XPER) Income Statement & Financial Overview
View the income breakdown for Xperi Inc. XPER across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $87.67M | $122.36M | $132.89M | $119.59M |
| Cost of Revenue | $0.00 | $27.56M | $27.48M | $28.95M |
| Gross Profit | $87.67M | $94.80M | $105.41M | $90.64M |
| Gross Profit Ratio | $1.00 | $0.77 | $0.79 | $0.76 |
| R&D Expenses | $16.47M | $42.16M | $53.63M | $45.12M |
| SG&A Expenses | $28.43M | $52.17M | $56.48M | $53.10M |
| Operating Expenses | $64.83M | $109.08M | $123.96M | $112.55M |
| Total Costs & Expenses | $64.83M | $136.65M | $151.45M | $141.50M |
| Interest Income | $0.00 | -$3.88M | $2.38M | $1.29M |
| Interest Expense | -$10.65M | $756000.00 | $756000.00 | $748000.00 |
| Depreciation & Amortization | $19.59M | $13.22M | $13.85M | $14.32M |
| EBITDA | $22.84M | $72.95M | -$2.32M | -$6.30M |
| EBITDA Ratio | $0.26 | $0.60 | -$0.02 | -$0.05 |
| Operating Income | $22.84M | -$14.29M | -$18.55M | -$21.91M |
| Operating Income Ratio | $0.26 | -$0.12 | -$0.14 | -$0.18 |
| Other Income/Expenses (Net) | -$8.94M | $73.26M | $4.65M | $542000.00 |
| Income Before Tax | $13.90M | $58.98M | -$13.91M | -$21.36M |
| Income Before Tax Ratio | $0.16 | $0.48 | -$0.10 | -$0.18 |
| Income Tax Expense | $2.08M | -$3.99M | $2.90M | $9.27M |
| Net Income | $11.81M | $46.22M | -$16.80M | -$30.30M |
| Net Income Ratio | $0.13 | $0.38 | -$0.13 | -$0.25 |
| EPS | $0.11 | $1.02 | -$0.37 | -$0.67 |
| Diluted EPS | $0.10 | $1.02 | -$0.37 | -$0.67 |
| Weighted Avg Shares Outstanding | $45.06M | $45.37M | $45.68M | $45.33M |
| Weighted Avg Shares Outstanding (Diluted) | $45.06M | $45.37M | $45.68M | $45.33M |
The company's financials show resilient growth, with revenue advancing from $119.59M in Q2 2024 to $87.67M in Q1 2025. Gross profit remained healthy with margins at 100% in Q1 2025 compared to 76% in Q2 2024. Operating income hit $22.84M last quarter, sustaining a consistent 26% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $22.84M. Net income dropped to $11.81M, while earnings per share reached $0.11. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan